Clinical trial
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With…
NCT00301301 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00301301 |
|---|---|
| Title | A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Non-Hodgkins Lymphoma |
| Intervention type | Drug |
| Interventions | Gemcitabine, Cisplatinum, Rituximab |
| Enrollment | 39 |
| First posted | Mar 10, 2006 |
| Last update posted | Jan 12, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: